Ensitrelvir
Ensitrelvir (S-217622) is an orally bioavailable 3CL protease inhibitor for SARS-CoV-2, exhibiting potent antiviral activity with an IC50 of 13 nM. It is a valuable research tool for studying coronavirus replication and has demonstrated efficacy in both in vitro assays and in vivo animal models of infection.
Product Specifications
CAS Number
2647530-73-0
Product Name Alternative
S 217622, S217622, S-217622, SARS-CoV-2 3CL, SARS-CoV, SARSCoV, SARS coronavirus, Virus Protease, variant, oral, intrapulmonary replication, inhibit, Ensitrelvir, Inhibitor, COVID-19
Field of Research
Infectious Disease & Virology
Purity
99.57% (May vary between batches)
Solubility
DMSO:160 mg/mL (300.82 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.52 mM)
Smiles
Cn1nc (cc (c (/N=C (\NC (N2Cc3nn (C) cn3) =O) /N (Cc (cc (c (F) c3) F) c3F) C2=O) c2) Cl) c2c1
Molecular Formula
C22H17ClF3N9O2
Molecular Weight
531.88
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog